Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ALPMF - FDA accepts Pfizer's marketing application for expanded use of Xtandi


ALPMF - FDA accepts Pfizer's marketing application for expanded use of Xtandi

  • Pfizer (NYSE:PFE) and collaboration partner Astellas Pharma (OTCPK:ALPMF) announce that the FDA has accepted under Priority Review the former's marketing application seeking approval for XTANDI (enzalutamide) for the treatment of men with non-metastatic castration-resistant prostate cancer (CRPC).
  • More news on: Pfizer Inc., Astellas Pharma, Inc., Healthcare stocks news,
  • Read more ...
Stock Information

Company Name: Astellas Pharma Inc
Stock Symbol: ALPMF
Market: OTC

Menu

ALPMF ALPMF Quote ALPMF Short ALPMF News ALPMF Articles ALPMF Message Board
Get ALPMF Alerts

News, Short Squeeze, Breakout and More Instantly...